Medical Market Report

Global Liquid Biopsy Products Market By Type (CTC, ctDNA, and Exosomes), By Application (Blood Sample, Urine Sample, and Bio Fluids), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 134423
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Liquid Biopsy Products Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global liquid biopsy products market is segmented on the basis of Type, Application, and geography.
    The global Liquid Biopsy Products market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Liquid Biopsy Products Market Scope:

    By type, the market is segmented into CTC, ctDNA, and Exosomes. By Application, the market is divided into Blood Sample, Urine Sample, and Bio Fluids. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, and Angle plc.

    Key Market Segments

    Type

    CTC
    ctDNA
    Exosomes

    Application

    Blood Sample
    Urine Sample
    Bio Fluids

    Key Market Players included in the report:

    RainDanceTechnologies
    Biocartis
    Qiagen
    Guardant Health
    MDxHealth
    Pathway Genomics
    NeoGenomics Laboraories
    Sysmex Inostics
    Cynvenio
    Menarini Silicon Biosystems
    Adaptive Biotechnologies
    Biocept
    Angle plc

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Liquid Biopsy Products Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Liquid Biopsy Products Market, high-growth regions, and market drivers, restraints, and also market chances.
    The analysis covers Liquid Biopsy Products Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Liquid Biopsy Products Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Liquid Biopsy Products Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Liquid Biopsy Products Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Liquid Biopsy Products sub-markets, depending on key regions (various vital states).
    To analyze Liquid Biopsy Products Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Liquid Biopsy Products Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Liquid Biopsy Products Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Liquid Biopsy Products Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Liquid Biopsy Products Market Overview
    

    3.1. Liquid Biopsy Products Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Liquid Biopsy Products Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Liquid Biopsy Products Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. CTC
    
4.4. ctDNA
    
4.5. Exosomes5. Global Liquid Biopsy Products Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Liquid Biopsy Products Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Blood Sample
    
5.4. Urine Sample
    
5.5. Bio Fluids6. Global Liquid Biopsy Products Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Liquid Biopsy Products Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2. Europe
    

    6.2.1. Europe Liquid Biopsy Products Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Liquid Biopsy Products Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Liquid Biopsy Products Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Liquid Biopsy Products Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Liquid Biopsy Products Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. RainDanceTechnologies
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Biocartis
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Qiagen
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Guardant Health
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. MDxHealth
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Pathway Genomics
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. NeoGenomics Laboraories
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Sysmex Inostics
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Cynvenio
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Menarini Silicon Biosystems
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Adaptive Biotechnologies
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Biocept
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. Angle plc
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.